2024-03-05T23:39:22.565Z

103 Hummingbird

103 Hummingbird
Lung cancer

A Phase 1b Study to Evaluate HMBD-001 in Combination with Docetaxel with or without Cetuximab in Participants with Advanced Squamous Non-Small Cell Lung Cancers (HMBD-001-103 Hummingbird)

A Phase 1b Study to Evaluate HMBD-001 in Combination with Docetaxel with or without Cetuximab in Participants with Advanced Squamous Non-Small Cell Lung Cancers (HMBD-001-103 Hummingbird)

Trial overview

Topic

Lung Cancer

Trial registration

Number: NCT05910827

Study details

This is a phase 1b multi-center, open-label study of HMBD-001 with or without chemotherapy in participants with advanced solid tumors harboring NRG1 gene fusions.

Further information
Location

GenesisCare North Shore – PI: Dr Nick Pavlakis

GenesisCare North Shore – PI: Dr Nick Pavlakis :::

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.